Tela Bio
Yahoo Finance • 10 months ago
TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
MALVERN, Pa., Nov. 16, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioriti... Full story
Yahoo Finance • 10 months ago
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., Nov. 10, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcome... Full story
Yahoo Finance • 10 months ago
TELA Bio Reports Third Quarter 2023 Financial Results
MALVERN, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizi... Full story
Yahoo Finance • 11 months ago
TELA Bio to Announce Third Quarter 2023 Financial Results
MALVERN, Pa., Oct. 26, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcome... Full story
Yahoo Finance • last year
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
MALVERN, Pa., Sept. 18, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by priorit... Full story
Yahoo Finance • last year
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
MALVERN, Pa., Aug. 16, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioriti... Full story
Yahoo Finance • last year
New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options
MALVERN, Pa., June 15, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioriti... Full story
Yahoo Finance • last year
TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab
MALVERN, Pa., May 19, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and... Full story
Yahoo Finance • last year
Q1 2023 TELA Bio Inc Earnings Call
Participants Antony Koblish; Co-founder, President, CEO & Director; TELA Bio, Inc. Louisa Smith Roberto E. Cuca; CFO & COO; TELA Bio, Inc. David Louis Turkaly; MD & Equity Research Analyst; JMP Securities LLC, Research Division Frank... Full story
Yahoo Finance • last year
TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference
MALVERN, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritiz... Full story
Yahoo Finance • last year
TELA Bio to Participate in the JMP Securities Life Sciences Conference
MALVERN, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing th... Full story
Yahoo Finance • last year
TELA Bio to Announce First Quarter 2023 Financial Results
MALVERN, Pa., April 27, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcom... Full story
Yahoo Finance • last year
TELA Bio Announces Proposed Public Offering of Common Stock
MALVERN, Pa., April 18, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing... Full story
Yahoo Finance • last year
TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023
MALVERN, Pa., March 29, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by priorit... Full story
Yahoo Finance • last year
TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
MALVERN, Pa., March 23, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation a... Full story
Yahoo Finance • 2 years ago
TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results
MALVERN, Pa., March 21, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritiz... Full story
Yahoo Finance • 2 years ago
TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications
MALVERN, Pa., March 16, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by priorit... Full story
Yahoo Finance • 2 years ago
TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results
MALVERN, Pa., Feb. 28, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcome... Full story
Yahoo Finance • 2 years ago
TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques
MALVERN, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation an... Full story
Yahoo Finance • 2 years ago
TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization
MALVERN, Pa., Feb. 14, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation an... Full story
